Core Insights - Investing in dividend-paying stocks is an effective way to generate passive income, with Healthpeak Properties, Realty Income, and Stag Industrial highlighted as top choices for monthly dividends [1] Group 1: Healthpeak Properties - Healthpeak Properties is a REIT focused on the healthcare sector, leasing properties such as outpatient medical buildings and senior housing, providing stable rental income [3] - The company switched to a monthly dividend schedule in April, currently paying $0.10167 per share monthly, equating to an annual payout of $1.22, resulting in a yield of over 7% [4] - Healthpeak's latest dividend rate is 2% higher than in 2024, with an estimated financial flexibility of $500 million to $1 billion for future investments or share repurchases [5] Group 2: Realty Income - Realty Income, known as "The Monthly Dividend Company," declared its 659th consecutive monthly dividend in May, with a payout of $0.2685 per share in mid-June, yielding nearly 6% [6][7] - The company has raised its dividend 130 times since its public listing in 1994, maintaining a consistent increase for the past 110 quarters [8] - Realty Income plans to invest around $4 billion this year, supported by a low payout ratio of 75% of adjusted FFO, allowing for continued portfolio and payout growth [9] Group 3: Stag Industrial - Stag Industrial owns a diversified portfolio of industrial properties, paying about two-thirds of its cash flow in dividends, which allows for over $100 million annually for new investments [10] - The next monthly dividend of $0.12167 per share will be paid on July 15, providing a yield of over 4% at the current share price [10] - Stag Industrial plans to invest between $350 million and $650 million into new properties this year, focusing on stabilized properties and those with redevelopment potential [11] Group 4: Summary of Investment Opportunities - Healthpeak Properties, Realty Income, and Stag Industrial are identified as high-yielding monthly dividend stocks with potential for future growth, making them attractive options for passive income seekers [12]

Brad Thomas has over 30 years of real estate investing experience and has acquired, developed, or brokered over $1B in commercial real estate transactions. He has been featured in Barron's, Bloomberg, Fox Business, and many other media outlets. He's the author of four books, including the latest, REITs For Dummies. Analyst's Disclosure: I/we have a beneficial long position in the shares of O, EGP, DOC, IRET either through stock ownership, options, or other derivatives. I wrote this article myself, and it ex ...

Summary of Healthpeak Properties Conference Call Company Overview - Healthpeak Properties is a real estate investment trust (REIT) with a market capitalization of approximately $25 billion, focusing on healthcare real estate, primarily in outpatient medical facilities (60% of business), senior housing (10%), and life sciences/lab facilities (30%) [2][3] Core Business Insights - Healthpeak is the largest owner of outpatient medical facilities globally and the second or third largest owner of lab life sciences facilities [2][3] - The company has a strong tenant base, with HCA (largest for-profit health system) and CommonSpirit (largest non-profit health system) as significant tenants [4][5] - Healthpeak has demonstrated resilience during the pandemic, collecting 99% of rent and maintaining occupancy rates [7][8] Market Dynamics - The outpatient medical sector is experiencing consistent growth due to demographic trends, with 12,000 people turning 65 daily, leading to increased demand for healthcare services [12][35] - The average rent for outpatient medical space is approximately $23 per square foot, while new construction costs are significantly higher at $35 to $40 per square foot, making existing properties more attractive [13][15] - Healthpeak's outpatient medical facilities are strategically located in fast-growing markets such as Atlanta, Dallas, and Phoenix [10] Lab Space Insights - The lab real estate market has seen a temporary oversupply due to increased construction during the pandemic, leading to challenges in recruiting new tenants [22][24] - Healthpeak operates in key markets like Boston, South San Francisco, and San Diego, where demand for lab space remains strong despite current oversupply [18][22] - The company emphasizes the importance of collaboration in lab environments, providing amenities that facilitate interaction among scientists [19][20] Financial Performance and Growth - Healthpeak offers a 7% dividend based on its current stock price, with a payout ratio of 70% of cash flow [24] - The company is focused on leasing the remaining 15% of its lab space, which could generate an additional $60 to $75 million in annual rent [43] - Future growth is anticipated from the aging population and the increasing shift of healthcare services to outpatient settings [35][36] Regulatory and Funding Environment - The company is monitoring NIH funding and its impact on the lab space, noting that while direct funding remains stable, the overall capital markets have slowed down [37][40] - Healthpeak is strategically investing in "zombie buildings" through loans to capitalize on future demand once the market stabilizes [44][32] Conclusion - Healthpeak Properties is well-positioned for growth in both outpatient medical and lab spaces, leveraging demographic trends and strategic partnerships with health systems. The company remains resilient in the face of market challenges and is focused on long-term growth opportunities in the healthcare real estate sector [46][47]

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What a ...

Healthpeak Properties (DOC) Q1 2025 Earnings Call April 25, 2025 07:01 PM ET Company Participants Andrew Johns - Senior Vice President, Investor RelationsScott Brinker - CEO, President & DirectorKelvin Moses - CFOFarrell Granath - Equity Research AssociateScott R. Bohn - Chief Development Officer and Co-Head of Life ScienceSeth Bergey - Senior Research AssociateRich Anderson - Managing DirectorVikram Malhotra - Managing DirectorMichael Carroll - Managing Director & Head of US Real Estate ResearchRobin Hanel ...

Calko Medical Building Brooklyn, NY Earnings Release and Supplemental Report First Quarter 2025 ___________________________________________________________________ To learn more about Healthpeak's commitment to responsible business and view our most recent Corporate Impact Report, please visit www.healthpeak.com/corporate-impact. Return to TOC 3 – Net income of $0.06 per share, Nareit FFO of $0.45 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.43 per share, and Total Same-Store Portfolio Cash (Ad ...

Core Viewpoint - Healthpeak Properties, Inc. reported first-quarter 2025 funds from operations (FFO) as adjusted per share of 46 cents, meeting expectations and showing a slight increase from 45 cents in the prior year, driven by better-than-anticipated revenues despite higher interest expenses [1][2]. Financial Performance - The company generated revenues of $702.9 million, exceeding the Zacks Consensus Estimate of $691.9 million, representing a year-over-year increase of 15.9% [2]. - Healthpeak reported a 7% year-over-year growth in total merger-combined same-store cash (adjusted) net operating income (NOI) [3]. - The outpatient medical and lab segments experienced year-over-year growth of 5% and 7.7%, respectively, while the Continuing Care Retirement Communities (CCRC) segment reported a growth of 15.9% [3]. Lease Activity - In the reported quarter, Healthpeak executed lab new and renewal leases totaling 276,000 square feet, achieving a retention rate of 88% and +5% cash-releasing spreads on renewals [4]. - For the outpatient medical portfolio, new and renewal leases totaled 973,000 square feet, with a retention rate of 86% and +4% cash-releasing spreads on renewals [4]. Balance Sheet - As of March 31, 2025, Healthpeak had cash and cash equivalents of $70.6 million, down from $119.8 million at the end of 2024, with a net debt to adjusted EBITDAre ratio of 5.2X [5]. - The company repurchased 5.1 million shares at a weighted average price of $18.50, totaling $94 million, from the beginning of the year through April 24 [5]. 2025 Outlook - Healthpeak reaffirmed its guidance for 2025, expecting FFO as adjusted per share to be between $1.81 and $1.87, with the Zacks Consensus Estimate at $1.85 [6]. - The company anticipates total merger-combined same-store cash (adjusted) NOI growth in the range of 3-4% for the year [6].

Core Insights - Healthpeak reported revenue of $702.89 million for the quarter ended March 2025, reflecting a year-over-year increase of 15.9% and a surprise of +0.98% over the Zacks Consensus Estimate of $696.06 million [1] - The company's EPS for the quarter was $0.46, which is a significant increase from $0.01 in the same quarter last year, aligning with the consensus EPS estimate [1] Revenue Breakdown - Resident fees and services generated $148.93 million, slightly above the average estimate of $147.18 million from three analysts [4] - Rental and related revenues amounted to $538.14 million, exceeding the average estimate of $527.49 million from three analysts, representing a year-over-year change of +16.5% [4] - Interest income and other revenues were reported at $15.82 million, below the estimated $16.97 million, but showed a substantial year-over-year increase of +175.1% [4] Stock Performance - Healthpeak's shares have returned -7.3% over the past month, compared to a -5.1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

分组1 - Healthpeak reported quarterly funds from operations (FFO) of $0.46 per share, matching the Zacks Consensus Estimate and showing an increase from $0.45 per share a year ago [1] - The company achieved revenues of $702.89 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 0.98% and up from $606.56 million year-over-year [2] - Over the last four quarters, Healthpeak has surpassed consensus FFO estimates three times and topped consensus revenue estimates four times [2] 分组2 - The stock's immediate price movement will depend on management's commentary during the earnings call and future FFO expectations [3][4] - Healthpeak shares have declined approximately 7.2% year-to-date, compared to a decline of 8.6% for the S&P 500 [3] - The current consensus FFO estimate for the upcoming quarter is $0.46 on revenues of $696.26 million, and for the current fiscal year, it is $1.85 on revenues of $2.8 billion [7] 分组3 - The estimate revisions trend for Healthpeak is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] - The REIT and Equity Trust - Other industry is currently in the bottom 40% of Zacks industries, which may impact stock performance [8]

Core Viewpoint - Healthpeak is expected to report quarterly earnings of $0.46 per share, reflecting a year-over-year increase of 2.2%, with revenues projected at $694.72 million, up 14.5% from the previous year [1]. Group 1: Earnings Estimates - Analysts have maintained the consensus EPS estimate for the upcoming quarter over the last 30 days, indicating stability in their assessments [1]. - The projected 'Revenues- Rental and related revenues' is expected to reach $527.49 million, showing a year-over-year increase of 14.2% [4]. - 'Revenues- Interest income and other' is anticipated to be $16.97 million, representing a significant year-over-year increase of 195.1% [4]. Group 2: Depreciation and Amortization - Analysts estimate 'Depreciation and amortization' to be $274.46 million, compared to $219.22 million reported in the same quarter last year [5]. Group 3: Stock Performance - Over the past month, Healthpeak shares have decreased by 6.4%, while the Zacks S&P 500 composite has declined by 5.6% [5]. - Healthpeak currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [5].